Search

Your search keyword '"Deborah T. Blumenthal"' showing total 14 results

Search Constraints

Start Over You searched for: Author "Deborah T. Blumenthal" Remove constraint Author: "Deborah T. Blumenthal" Publisher american society of clinical oncology (asco) Remove constraint Publisher: american society of clinical oncology (asco)
14 results on '"Deborah T. Blumenthal"'

Search Results

1. Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance

2. Verification of statistical oncological endpoints on encrypted data: Confirming the feasibility of real-world data sharing without the need to reveal protected patient information

3. Updated safety/feasibility study of concurrent tumor treating fields (TTFields) and radiation therapy for newly diagnosed glioblastoma

4. Safety of tumor treating fields and concomitant radiotherapy for newly diagnosed glioblastoma

5. Short Delay in Initiation of Radiotherapy May Not Affect Outcome of Patients With Glioblastoma: A Secondary Analysis From the Radiation Therapy Oncology Group Database

6. Treatment through progression with ofranogene obadenovec (VB-111), an anti-cancer viral therapy, significantly attenuates tumor growth in recurrent GBM: Individual phase 2 patient data

7. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG oncology/RTOG 0525 and 0825

8. Ofranogene obadenovec (VB-111), an anti-cancer gene therapy in combination with bevacizumab to improve overall survival compared to bevacizumab monotherapy in patients with rGBM: A phase 2 historically controlled trial

9. Comprehensive genomic profiling of primary intracranial malignant neoplasms to reveal frequency of clinically relevant genomic alterations

10. RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM)

11. Molecular predictors of outcome and response to bevacizumab (BEV) based on analysis of RTOG 0825, a phase III trial comparing chemoradiation (CRT) with and without BEV in patients with newly diagnosed glioblastoma (GBM)

12. RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM)

13. A common sense approach to radiation treatment planning of temporal lobe GBM

14. RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligodendrogliomas

Catalog

Books, media, physical & digital resources